TAG:
cap
LabCorp And Quest Report 3rd Quarter Financial Performance
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
CEO Summary: In third quarter earnings reports, both national lab companies posted modest gains in specimen volume, revenue, and net profit. More telling is the relative quiet in the current market for lab testing services. With no obvious opportunities to fuel double-digit rates of growt…
Medi-Cal Hits Pathologist For $6.4 Million Payment
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
CEO SUMMARY: Once again, government health bureaucrats are overreaching in their efforts to reduce spending and collect money from any source. A California pathologist has been hit with a Medi-Cal demand for $6.4 million in repayments, simply because he served as laboratory director for t…
Rapid Genome Sequencing Predicted by Mid-2009
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: In the same way that the Human Genome Project was disrupted by the entry of C. Craig Venter and Perkin-Elmer in what was then a 15-year, $3 billion project, now Complete Genetics of Mountain View, California, is disrupting the race to the $1,000 human genome sequence. Develop…
Pathology Boot Camp to Address Three Trends
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: Anatomic pathology groups across the nation must develop effective strategies to address challenges in pricing, intensifying competition, and expensive new technologies. That’s the assertion of three pathology practice administrators who have organized a boot camp in Dallas…
Siemens, BioImagene, Clarient University of Pennsylvania, Mayo Clinic
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased…
Hospital Labs Have New Options for Molecular Dx
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: Laboratories that offer molecular assays continue to see strong growth in four areas: oncology, hematopathology, infectious diseases, and personalized medicine. Further, a new generation of molecular testing systems and analyzers is coming to market which will make it easier …
DeVry University, Retail Walk-In Clinics, NeoGenomics, Clarient, Clinical Lab Partners, Patient ID Theft
By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue
MED TECH SHORTAGE CAUSES DEVRY UNIVERSITY TO OFFER MT DEGREE IN RESPONSE TO THE GROWING SHORTAGE of skilled lab scientists and medical technologists, DeVry University of Phoenix, Arizona, is offering a new bachelor’s degree program in Clinical Laboratory Science (…
Implementation Date For ICD-10 Is Proposed
By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue
CEO SUMMARY: Even though the transition from ICD-9 to ICD-10 will not be required until 2011, laboratories and pathology groups should have a transition plan in place. ICD-10’s 155,000 seven-digit codes will replace the 17,000 five-digit codes of ICD-9. Because of major…
iTunes Business Model For Digital Path Scans
By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue
CEO SUMMARY: If BioImagene’s CEO is to be believed, the company is ready to deliver a digital pathology system that is robust and affordable, even in settings with just two or three pathologists. One key to the BioImagene strategy is “per scan” pricing that avoids the need for upfro…
September 29, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue
It’s been a productive year for Michigan Co-Tenancy Laboratory (MCL) of Ann Arbor, Michigan, which performs reference and esoteric testing for its members. During 2008, four hospital systems have come aboard as new co-tenants. They are: Baptist Health, Montgomery, …
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized